Although Wegovy (semaglutide) is often used as a weight-loss medicine, it is well-known to be protective for the heart.

On Friday, Novo Nordisk announced that the U.S. Food and Drug Administration (FDA) had approved Wegovy for the treatment of metabolic dysfunction-associated steatohepatitis (MASH). Wegovy has become a ...

DEAR DR. ROACH: I am a 52-year-old woman who was diagnosed with familial hypercholesterolemia in October 2024. I went through a cardiac workup for pain in my left arm and found this out.

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030.

GLP-1 drugs for diabetes and weight loss may influence patients’ cancer risk, usually lowering it but sometimes possibly increasing it, new findings suggest.

NEW YORK — (AP) — Wall Street held near its record heights on Monday, ahead of a week likely to be dominated by updates from ...

"This retrospective cohort study found that taking GLP-1RAs was associated with a reduced overall risk of cancer, including lower risks of endometrial, ovarian, and meningioma cancers, among patients ...

The most profitable trades in history often begin in moments of panic. And few moments felt more hopeless than the fall of 2008… As more and more borrowers began defaulting on their mortgages, the ...

FOR millions around the world, fat jabs like Mounjaro and Wegovy have been a godsend for a simple and stress-free way to shed those stubborn pounds. But if you want to make the most of them, you ...

Available webcasts will be accessible on Skye’s website.